D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the <a target=_blank href=h ...

Recommended Reading FDA approves Lumicell’s breast cancer imaging tool Siemens Healthineers received premarket approval for ...

Seitz’s extensive experience in buildings is instrumental to the future growth of Siemens’ buildings business.

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave" or the "Company"), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, today ...

By partnering with the Sponsors of Mass Save, the 2024 Climate Leaders accessed valuable resources and expertise, ultimately ...

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...

The Mammomat B.brilliant platform is Siemens’ first completely redesigned mammography system in over a decade.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, and the ...

The neurointerventional device market in the united states is on a robust growth trajectory, with projections indicating a ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Siemens Healthineers AG (SEMHF – Research ...

Baxter says Hurricane Helene's unprecedented rain and flooding in North Carolina has knocked its largest plant offline.

Medtronic leaned into its robotics and navigation strategy during the third quarter of 2024. Here are four things to know: 1. On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff ...